pms-Betahistine (2016-05-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Hospitals, Healthcare Professionals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 1410266A | pms-Betahistine | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| Tablet | DIN 2330237 | 24 mg |
Affected products
pms-Betahistine
Labelling error. The dosage on the carton (1/2 to 1 tablet three times daily) could result in exceeding the maximum daily dose of 48mg.
Wholesalers and pharmacies in Canada